CS
RXST icon

Credit Suisse’s RxSight RXST Stock Holding History

Credit Suisse’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.34M Buy
26,032
+2,628
+11% +$129K ﹤0.01% 2095
2023
Q4 		$944K Buy
23,404
+4,640
+25% +$136K ﹤0.01% 2365
2023
Q3 		$523K Sell
18,764
-1,089
-5% -$32.5K ﹤0.01% 2664
2023
Q2 		$572K Buy
+19,853
New +$442K ﹤0.01% 2706
2023
Q1 		– Sell
-1
Closed -$13 – 3643
2022
Q4 		$13 Sell
1
-114
-99% -$1.39K ﹤0.01% 3706
2022
Q3 		$1K Buy
115
+96
+505% +$1.32K ﹤0.01% 3919
2022
Q2 		$0 Buy
+19
New +$251 ﹤0.01% 4261

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Credit Suisse's RXST Position: Q1 2024 in Review

Credit Suisse increased its RxSight (RXST) stake by 11% in Q1 2024, buying an estimated $129K and bringing the position to 26,032 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Credit Suisse first reported a position in RXST in Q2 2022 and has held it in 7 quarters since. 197 funds tracked by Wall St. Rank hold RXST as of Q1 2024.

  • Credit Suisse held 26,032 shares of RxSight worth $1.34M as of Q1 2024.
  • Credit Suisse bought 2,628 RxSight shares in Q1 2024, an estimated $129K.
  • RxSight made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2095 holding.
  • Credit Suisse first reported a position in RxSight in Q2 2022 and has held it in 7 quarters since.
  • 197 funds tracked by Wall St. Rank held RxSight as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.